{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T07:40:47Z","timestamp":1793259647850,"version":"4.5.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100015278","name":"Pfizer Healthcare Ireland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015278","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013347","name":"ESICM","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","ejinme.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.ejim.2024.07.019","type":"journal-article","created":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T21:42:47Z","timestamp":1722289367000},"page":"100-110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Intra-abdominal infection and sepsis in immunocompromised intensive care unit patients: Disease expression, microbial aetiology, and clinical outcomes"],"prefix":"10.1016","volume":"129","author":[{"given":"Jos\u00e9-Artur","family":"Paiva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Rello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Eckmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3007-1670","authenticated-orcid":false,"given":"Massimo","family":"Antonelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kostoula","family":"Arvaniti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Despoina","family":"Koulenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2521-5326","authenticated-orcid":false,"given":"Georgios","family":"Papathanakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Dimopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6797-3147","authenticated-orcid":false,"given":"Mieke","family":"Deschepper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2145-0345","authenticated-orcid":false,"given":"Stijn","family":"Blot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ejim.2024.07.019_bib0001","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1097\/00003246-199206000-00025","article-title":"American College of Chest Physicians\/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis","volume":"20","author":"Bone","year":"1992","journal-title":"Crit Care Med"},{"issue":"8","key":"10.1016\/j.ejim.2024.07.019_bib0002","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.ejim.2024.07.019_bib0003","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/cid\/ciu789","article-title":"Is bacteremic sepsis associated with higher mortality in transplant recipients than in nontransplant patients? a matched case-control propensity adjusted study","volume":"60","author":"Kalil","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ejim.2024.07.019_bib0004","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1001\/archinte.1975.00330050089015","article-title":"Clinical presentation of infection in granulocytopenic patients","volume":"135","author":"Sickles","year":"1975","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ejim.2024.07.019_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.iccn.2023.103444","article-title":"Current approach to fever in the intensive care unit","volume":"78","author":"Guerreiro","year":"2023","journal-title":"Intensive Crit Care Nurs"},{"key":"10.1016\/j.ejim.2024.07.019_bib0006","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.2165\/00003495-200464190-00002","article-title":"Management of invasive candidiasis in critically ill patients","volume":"64","author":"Blot","year":"2004","journal-title":"DrugsDrugs"},{"key":"10.1016\/j.ejim.2024.07.019_bib0007","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/MCC.0000000000000637","article-title":"Diagnosing invasive pulmonary aspergillosis in ICU patients: putting the puzzle together","volume":"25","author":"Blot","year":"2019","journal-title":"Curr Opin Crit Care"},{"key":"10.1016\/j.ejim.2024.07.019_bib0008","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1053\/jhin.2002.1329","article-title":"Reappraisal of attributable mortality in critically ill patients with nosocomial bacteraemia involving Pseudomonas aeruginosa","volume":"53","author":"Blot","year":"2004","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.ejim.2024.07.019_bib0009","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1097\/TP.0b013e3182a049fd","article-title":"Risk factors and outcomes of bacteremia caused by drug-resistant ESKAPE pathogens in solid-organ transplant recipients","volume":"96","author":"Bodro","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.ejim.2024.07.019_bib0010","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1056\/NEJMra1208623","article-title":"Severe sepsis and septic shock","volume":"369","author":"Angus","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2024.07.019_bib0011","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/CCM.0b013e31822b50c2","article-title":"Survival in neutropenic patients with severe sepsis or septic shock","volume":"40","author":"Legrand","year":"2012","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ejim.2024.07.019_bib0012","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/CCM.0000000000000714","article-title":"Milwaukee initiative in critical care outcomes research group of investigators. Severe sepsis in hematopoietic stem cell transplant recipients","volume":"43","author":"Kumar","year":"2015","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ejim.2024.07.019_bib0013","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.cmi.2018.04.022","article-title":"Severe infections in critically ill solid organ transplant recipients","volume":"24","author":"Kalil","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ejim.2024.07.019_bib0014","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1111\/tri.13467","article-title":"Clinical and economic burden of infections in hospitalized solid organ transplant recipients compared with the general population in Canada\u2014A retrospective cohort study","volume":"32","author":"Hamandi","year":"2019","journal-title":"Transpl Int"},{"key":"10.1016\/j.ejim.2024.07.019_bib0015","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s11908-015-0487-4","article-title":"Sepsis in the severely immunocompromised patient","volume":"17","author":"Kalil","year":"2015","journal-title":"Curr Infect Dis Rep"},{"key":"10.1016\/j.ejim.2024.07.019_bib0016","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1097\/TP.0b013e31824bf219","article-title":"Staphylococcus aureus bacteremia in solid organ transplant recipients: evidence for improved survival when compared with nontransplant patients","volume":"93","author":"Malinis","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.ejim.2024.07.019_bib0017","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1093\/cid\/ciw295","article-title":"Inpatient mortality among solid organ transplant recipients hospitalized for sepsis and severe sepsis","volume":"63","author":"Donnelly","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"S2","key":"10.1016\/j.ejim.2024.07.019_bib0018","doi-asserted-by":"crossref","first-page":"S156","DOI":"10.1093\/infdis\/jiaa320","article-title":"Sepsis in immunocompromised patients without human immunodeficiency virus","volume":"222","author":"McCreery","year":"2020","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ejim.2024.07.019_bib0019","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1146\/annurev-physiol-061121-040214","article-title":"Sepsis-induced immunosuppression","volume":"84","author":"Torres","year":"2022","journal-title":"Ann Rev Physiol"},{"key":"10.1016\/j.ejim.2024.07.019_bib0020","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.636547","article-title":"Understanding and managing sepsis in patients with cancer in the era of antimicrobial resistance","volume":"8","author":"Gudiol","year":"2021","journal-title":"Front Med"},{"issue":"6","key":"10.1016\/j.ejim.2024.07.019_bib0021","first-page":"694","article-title":"Updated guideline on diagnosis and treatment of intraabdominal infections","volume":"82","author":"Armstrong","year":"2010","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.ejim.2024.07.019_bib0023","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1007\/s00134-019-05819-3","article-title":"Epidemiology of intra-abdominal infection and sepsis in critically ill patients: \u201cAbSeS\u201d, a multinational observational cohort study and ESICM Trials Group Project","volume":"45","author":"Blot","year":"2019","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ejim.2024.07.019_bib0024","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1097\/01.CCM.0000168253.91200.83","article-title":"International Sepsis Forum Definition of Infection in the ICU Consensus Conference. The international sepsis forum consensus conference on definitions of infection in the intensive care unit","author":"Calandra","year":"2005","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ejim.2024.07.019_bib0025","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.2165\/11599800-000000000-00000","article-title":"Essentials for selecting antimicrobial therapy for intra-abdominal infections","volume":"72","author":"Blot","year":"2012","journal-title":"DrugsDrugs"},{"key":"10.1016\/j.ejim.2024.07.019_bib0026","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1164\/ajrccm.157.2.9705064","article-title":"Ventilator-associated pneumonia caused by potentially drug-resistant bacteria","volume":"157","author":"Trouillet","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ejim.2024.07.019_bib0027","unstructured":"The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 5.0, 2015. http:\/\/www.eucast.org. Accessed 31 Mar 2014."},{"key":"10.1016\/j.ejim.2024.07.019_bib0028","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1093\/cid\/ciy378","article-title":"Difficult-to-treat resistance in gram-negative bacteremia at 173 US hospitals: retrospective cohort analysis of prevalence, predictors, and outcome of resistance to all firstline agents","volume":"67","author":"Kadri","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ejim.2024.07.019_bib0029","doi-asserted-by":"crossref","first-page":"ofz110","DOI":"10.1093\/ofid\/ofz110","article-title":"External validation of difficult-to-treat resistance prevalence and mortality risk in gram-negative bloodstream infection using electronic health record data from 140 US hospitals","volume":"6","author":"Kadri","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.ejim.2024.07.019_bib0030","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1089\/sur.2009.9930","article-title":"Diagnosis and manage ment of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America","volume":"11","author":"Solomkin","year":"2010","journal-title":"Surg Infect (Larchmt)"},{"key":"10.1016\/j.ejim.2024.07.019_bib0032","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1749-7922-9-37","article-title":"Complicated intra-abdominal infections worldwide: the definitive data of the CIAOW Study","volume":"9","author":"Sartelli","year":"2014","journal-title":"World J Emerg Surg"},{"issue":"Suppl","key":"10.1016\/j.ejim.2024.07.019_bib0033","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1016\/S0924-8579(12)70008-0","article-title":"Epidemiology and antimicrobial susceptibility profiles of Gram-negative bacteria causing urinary tract infections in the Asia-Pacific region: 2009\u20132010 results from the Study for Monitoring Antimicrobial Resistance Trends (SMART)","volume":"40","author":"Lu","year":"2012","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ejim.2024.07.019_bib0034","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s11596-020-2152-x","article-title":"Clinical and microbiological characteristics of patients with complicated intra-abdominal infections in intensive care unit","volume":"40","author":"Xiong","year":"2020","journal-title":"Curr Med Sci"},{"key":"10.1016\/j.ejim.2024.07.019_bib0035","doi-asserted-by":"crossref","first-page":"e309","DOI":"10.3346\/jkms.2019.34.e309","article-title":"Antimicrobial susceptibility of microorganisms isolated from patients with intraabdominal infection in Korea: a multicenter study","volume":"34","author":"Yoon","year":"2019","journal-title":"J Korean Med Sci"},{"issue":"7","key":"10.1016\/j.ejim.2024.07.019_bib0036","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1089\/sur.2020.396","article-title":"Is the isolation of Pseudomonas aeruginosa associated with outcomes from intra-abdominal infection? No, but the receipt of an empiric anti-pseudomonal agent is","volume":"22","author":"Chou","year":"2021","journal-title":"Surg Infect"},{"key":"10.1016\/j.ejim.2024.07.019_bib0037","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1186\/1471-2334-14-420","article-title":"Abdominal infections in the intensive care unit: characteristics, treatment and determinants of outcome","volume":"14","author":"De Waele","year":"2014","journal-title":"BMC Infect Dis"},{"issue":"1","key":"10.1016\/j.ejim.2024.07.019_bib0038","doi-asserted-by":"crossref","first-page":"R20","DOI":"10.1186\/cc8877","article-title":"Risk factors for multidrug resistant bacteria and optimization of empirical antibiotic therapy in postoperative peritonitis","volume":"14","author":"Augustin","year":"2010","journal-title":"Crit Care"},{"issue":"4","key":"10.1016\/j.ejim.2024.07.019_bib0039","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.ijantimicag.2018.11.001","article-title":"Ceftolozane\/tazobactam for the treatment of serious Pseudomonas aeruginosa infections: a multicentre nationwide clinical experience","volume":"53","author":"Bassetti","year":"2019","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"10.1016\/j.ejim.2024.07.019_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2014.08.011","article-title":"Invasive Candida infections in surgical patients in intensive care units: a prospective, multicentre survey initiated by the European Confederation of Medical Mycology (ECMM) (2006\u20132008)","volume":"21","author":"Klingspor","year":"2015","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"10.1016\/j.ejim.2024.07.019_bib0041","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1097\/01.CCM.0000053525.49267.77","article-title":"Can yeast isolation in peritoneal fluid be predicted in intensive care unit patients with peritonitis?","volume":"31","author":"Dupont","year":"2003","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ejim.2024.07.019_bib0042","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13054-015-0790-3","article-title":"Can yeast isolation be predicted in complicated secondary non-postoperative intra-abdominal infections?","volume":"19","author":"Dupont","year":"2015","journal-title":"Crit Care"},{"key":"10.1016\/j.ejim.2024.07.019_bib0043","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/s40121-021-00585-6","article-title":"Risk factors for intra-abdominal candidiasis in intensive care units: results from EUCANDICU study","volume":"11","author":"Bassetti","year":"2022","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.ejim.2024.07.019_bib0044","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ijantimicag.2009.11.015","article-title":"Patterns of antimicrobial therapy in severe nosocomial infections: empiric choices, proportion of appropriate therapy, and adaptation rates \u2013 a multicentre, observational survey in critically ill patients","volume":"35","author":"Vogelaers","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ejim.2024.07.019_bib0045","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1200\/JCO.2012.47.2365","article-title":"Outcomes of critically ill patients with hematologic malignancies: prospective multicenter data from France and Belgium\u2013a groupe de recherche respiratoire en r\u00e9animation onco-h\u00e9matologique study","volume":"31","author":"Azoulay","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejim.2024.07.019_bib0046","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1097\/CCM.0B013E318165314B","article-title":"Temporal changes in management and outcome of septic shock in patients with malignancies in the intensive care unit","volume":"36","author":"P\u00e8ne","year":"2008","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ejim.2024.07.019_bib0047","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/CCM.0b013e3181c0349e","article-title":"Characteristics and outcomes of patients with cancer requiring admission to intensive care units: a prospective multicenter study","volume":"38","author":"Soares","year":"2010","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ejim.2024.07.019_bib0048","doi-asserted-by":"crossref","DOI":"10.1016\/j.iccn.2022.103227","article-title":"Healthcare-associated infections in intensive care units: changes in epidemiology, diagnosis, prevention, and contributions of new technologies","volume":"70","author":"Blot","year":"2022","journal-title":"Intensive Crit Care Nurs"},{"key":"10.1016\/j.ejim.2024.07.019_bib0049","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1378\/chest.13-2618","article-title":"Sepsis severe or septic shock: outcome according to immune status and immunodeficiency profile","volume":"146","author":"Tolsma","year":"2014","journal-title":"ChestChest"},{"key":"10.1016\/j.ejim.2024.07.019_bib0050","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1097\/CCM.0000000000002722","article-title":"Time course of septic shock in immunocompromised and nonimmunocompromised patients","volume":"45","author":"Jamme","year":"2017","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ejim.2024.07.019_bib0051","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s13054-018-2099-5","article-title":"Clinical characteristics and prognosis of bacteraemia during postoperative intraabdominal infections","volume":"22","author":"Alqarni","year":"2018","journal-title":"Crit Care"},{"key":"10.1016\/j.ejim.2024.07.019_bib0052","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2022.106591","article-title":"Epidemiology and age-related mortality in critically ill patients with intra-abdominal infection or sepsis: an international cohort study","volume":"60","author":"Arvaniti","year":"2022","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ejim.2024.07.019_bib0053","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1007\/s00134-022-06883-y","article-title":"Poor timing and failure of source control are risk factors for mortality in critically ill patients with secondary peritonitis","volume":"48","author":"De Pascale","year":"2022","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ejim.2024.07.019_bib0054","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s13054-020-02917-3","article-title":"Phenotypic heterogeneity by site of infection in surgical sepsis: a prospective longitudinal study","volume":"24","author":"Stortz","year":"2020","journal-title":"Crit Care"},{"key":"10.1016\/j.ejim.2024.07.019_bib0055","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1097\/TA.0b013e318256e000","article-title":"Persistent inflammation and immunosuppression: a common syndrome and new horizon for surgical intensive care","volume":"72","author":"Gentile","year":"2012","journal-title":"J Trauma Acute Care Surg"},{"key":"10.1016\/j.ejim.2024.07.019_bib0056","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.3389\/fimmu.2018.01511","article-title":"Chronic critical illness and the persistent inflammation, immunosuppression, and catabolism syndrome","volume":"9","author":"Hawkins","year":"2018","journal-title":"Front Immunol"},{"issue":"8","key":"10.1016\/j.ejim.2024.07.019_bib0057","article-title":"Long-term host immune response trajectories among hospitalized patients with sepsis","volume":"2","author":"Yende","year":"2019","journal-title":"JAMA New Open"},{"key":"10.1016\/j.ejim.2024.07.019_bib0058","first-page":"2031","article-title":"Does immunosuppression affect the course of septic shock?","volume":"45","author":"Aygencel","year":"2017","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ejim.2024.07.019_bib0059","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/j.amjsurg.2020.07.016","article-title":"Abdominal sepsis patients have a high incidence of chronic critical illness with dismal long-term outcomes","author":"Cox","year":"2020","journal-title":"Am J Surg"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620524003133?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620524003133?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T01:18:20Z","timestamp":1732497500000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620524003133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":57,"alternative-id":["S0953620524003133"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2024.07.019","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intra-abdominal infection and sepsis in immunocompromised intensive care unit patients: Disease expression, microbial aetiology, and clinical outcomes","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2024.07.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 European Federation of Internal Medicine. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}